[1]孙媛媛,张明智.HBV感染与弥漫大B细胞淋巴瘤相关性研究进展[J].郑州大学学报(医学版),2019,(04):534-537.[doi:10.13705/j.issn.1671-6825.2018.11.051]
点击复制

HBV感染与弥漫大B细胞淋巴瘤相关性研究进展()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2019年04期
页码:
534-537
栏目:
综述
出版日期:
2019-07-20

文章信息/Info

作者:
孙媛媛张明智
郑州大学第一附属医院肿瘤科 郑州 450052
关键词:
乙型肝炎病毒 弥漫大B细胞淋巴瘤
DOI:
10.13705/j.issn.1671-6825.2018.11.051

参考文献/References:

[1] 孙媛媛,张明智.乙型肝炎病毒感染的弥漫大B细胞淋巴瘤患者临床特点及预后分析[J].医学研究生学报,2019,32(3):253
[2] 单丽珠,宋腾,王华庆,等.HBV感染弥漫大B细胞淋巴瘤的临床特点和预后分析[J].实用肿瘤杂志,2016,31(2):163
[3] 梁晓峰,陈园生,王晓军,等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655
[4] LI M,GAN Y,FAN C,et al.Hepatitis B virus and risk of non-Hodgkin lymphoma:an updated meta-analysis of 58 studies[J].J Viral Hepat,2018,25(8):894
[5] 魏岩,冯谦,董宇明.非霍奇金淋巴瘤与乙型肝炎病毒感染的相关性研究[J].中国现代医生,2018,56(5):44
[6] 贺冠强.肝炎病毒与非霍奇金淋巴瘤关系的研究进展[J].医学综述,2012,18(1):61
[7] CHEN J,WANG J,YANG J,et al.Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy[J].PLoS One,2013,8(7):e69400
[8] WANG C,XIA B,NING Q,et al.High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China[J].Ann Hematol,2018,97(3):453
[9] 陈万贞,尹海庆.B细胞非霍奇金淋巴瘤与乙型肝炎病毒感染相关性分析[J].临床医学,2018,38(3):34
[10]李晓利,张希远,史春雷,等.HBV感染的B细胞型非霍奇金淋巴瘤病人临床特征及预后分析[J].齐鲁医学杂志,2017,32(3):265
[11]雷雯,董丽华,张利娟,等.非霍奇金淋巴瘤与乙型肝炎病毒感染的关系[J].临床血液学杂志,2015,28(1):44
[12]冯燕,王新卫,刘新年,等.乙型肝炎病毒感染与弥漫大B细胞淋巴瘤的关系研究[J].中华医院感染学杂志,2016,26(13):2887
[13]韦花媚,罗春英,刘坤平,等.乙型肝炎病毒感染与弥漫大B细胞淋巴瘤临床、病理及预后的关系[J].中国老年学杂志,2015,35(9):2455
[14]罗曌,白洋禄,郭宝平,等.HBsAg阳性弥漫大B细胞淋巴瘤的临床病理特征和预后分析[J].广西医科大学学,2018,35(6):831
[15]LAW MF,LAI HK,CHAN HN,et al.The impact of hepatitis B virus(HBV)infection on clinical outcomes of patients with diffuse large B-cell lymphoma[J].Eur J Cancer Care(Engl),2015,24(1):117
[16]AL-MANSOUR MM,ALGHAMDI SA,ALSUBAIE MA,et al.Negative effect of hepatitis in overall and progression-free survival among patients with diffuse large B-cell lymphoma[J].Infect Agent Cancer,2018,13:18
[17]YAN X,ZHOU M,LOU ZZ,et al.Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera era:unique clinical features and worse outcomes[J].J Cancer Res Ther,2018,14(1):S248
[18]DENG L,SONG Y,YOUNG KH,et al.Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin[J].Oncotarget,2015,6(28):25061
[19]GUO W,ZHANG WX,LIU CS,et al.Clinical analysis of the HBV infection status of 135 patients with diffuse large B cell lymphoma treated with R-CHOP or CHOP/CHOP-like chemotherapy[J].PLoS One,2015,10(6):e0129064
[20]刘卫平,郑文,王贵强,等.乙型肝炎病毒与非霍奇金淋巴瘤关系的研究进展[J].白血病·淋巴瘤,2009,18(3):178
[21]李威,刘斌,杨帆,等.乙型肝炎病毒感染和弥漫大B细胞淋巴瘤相关性研究进展[J].现代肿瘤医学,2016,24(17):2812
[22]WANG YC,WANG HJ,PAN SK,et al.Capable infection of hepatitis B virus in diffuse large B-cell lymphoma[J].J Cancer,2018,9(9):1575
[23]ZHAO XY,GUO XD,XING LB,et al.HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma[J].Cell Death Dis,2018,9(2):61
[24]REN WC,YE XF,SU H,et al.Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma[J].Blood,2018,131(24):2670
[25]VISENTINI M,CASATO M.HBV messing with the B-cell genome leads to DLBCL[J].Blood,2018,131(24):2602
[26]HOGFELDT T,JAING C,MC LOUGHLIN K,et al.Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions[J].Oncol Lett,2016,12(4):2782
[27]LIU ZH,LI SY,LIU YM,et al.PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection[J].PLoS One,2017,12(6):e0180390
[28]LIU ZH,LI SY,GUO W,et al.MYC gene rearrangements are closely associated with poor survival of diffuse large B cell lymphoma with hepatitis B virus infection[J].Biomed Res Int,2017(2314):6133
[29]张宇,杨明珍.HBV相关弥漫大B细胞淋巴瘤临床特征、BCL-2、CMYC表达及预后分析[J].安徽医科大学学报,2017,52(4):570
[30]胡利娟,刘相富,胡小山,等.HBV与LDH对弥漫性大B细胞淋巴瘤患者化学治疗效果的影响:附144例报告[J].新医学,2015,46(12):808
[31]施伦波,赵燕,韩世伟,等.合并乙肝病毒感染对弥漫大B细胞淋巴瘤患者细胞免疫功能的影响[J].健康研究,2018,38(2):178
[32]魏征,程韵枫,王志梅,等.合并乙肝病毒感染对弥漫大B细胞淋巴瘤患者细胞免疫功能的影响[J].中国癌症杂志,2014,24(10):765
[33]CHOU CK,WANG LH,LIN HM,et al.Glucocorticoid stimulates hepatitis-B viral gene-expression in cultured human hepatoma-cells[J].Hepatology,1992,16(1):13
[34]CHENG AL,HSIUNG CA,SU IJ,et al.Steroid-free chemotherapy decreases risk of hepatitis B virus(HBV)reactivation in HBV-carriers with lymphoma[J].Hepatology,2003,37(6):1320
[35]ALI K,SIAL AA,BAIG MT,et al.Detection of the incidence of HBV,HCV infection and febrile neutropenia associated with CHOP with or without Rituximab in diffuse large B-cell lymphoma-treated patients[J].Hosp Pharm,2018,53(3):194
[36]季冬梅,曹军宁,洪小南,等.类RCHOP方案治疗弥漫大B细胞淋巴瘤后乙型肝炎病毒的激活情况:一项多中心回顾性研究[J].肿瘤,2010,30(7):608
[37]ELBEDEWY TA,ELASHTOKHY HE,RABEE ES,et al.Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening[J].J Egypt Natl Canc Inst,2015,27(1):11
[38]赵莹,王巍,林秀强,等.HBsAg(-)伴HBcAb(+)淋巴瘤患者免疫化疗后肝炎病毒再激活临床观察[J].中国癌症杂志,2012,22(4):312
[39]LU SS,XU Y,MU QT,et al.The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy[J].Leuk Lymphoma,2015,56(4):1027
[40]IANNITTO E,MINARDI V,CALVARUSO G,et al.Hepatitis B virus reactivation and alemtuzumab therapy[J].Eur J Haematol,2005,74(3):254
[41]LAW MF,HO R,CHEUNG CK,et al.Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy[J].World J Gastroenterol,2016,22(28):6484
[42]CHANG CS,TSAI CY,YAN SL.Hepatitis B reactivation in patients receiving targeted therapies[J].Hematology,2017,22(10):592
[43]XIE WZ,ZHOU D,HU KY,et al.Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy[J].Exp Ther Med,2013,6(1):109
[44]WU CY,HSIAO LT,CHIOU TJ,et al.Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B[J].Leuk Lymphoma,2015,56(8):2357
[45]石斌豪,郭丽颖,贾建伟.非霍奇金淋巴瘤合并乙型肝炎病毒感染的研究进展[J].中国病毒病杂志,2015,5(1):72
[46]LIN TY,HUANG H,LI XE.Treatment to prevent hepatitis B virus reactivation in patients with lymphoma receiving chemotherapy reply[J].JAMA,2015,313(12):1270
[47]中国临床肿瘤学会,中华医学会血液学分会,中国医师协会肿瘤医师考核委员会.淋巴瘤免疫化疗HBV再激活预防和治疗中国专家共识[J].临床肿瘤学杂志,2013,18(10):935
[48]吴勇,张天英,宋浏伟,等.抗PD-L1单抗的研制及其对乙型肝炎病毒的抑制效果初步研究[J].中国免疫学杂志,2016,32(7):1004

相似文献/References:

[1]张艳敏)),孙国清),张郑民),等.河南省艾滋病流行区HIV共感染HBV和HCV状况分析*[J].郑州大学学报(医学版),2009,(03):542.
 ZHANG Yanmin)),SUN Guoqing),ZHANG Zhengmin),et al.Relative analysis on HIV coinfected HBV and HCV in the area of epidemic disease, Henan[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(04):542.
[2]李志勤,余祖江,武淑环,等.干扰素α对不同基因型乙型肝炎病毒抗病毒疗效比较[J].郑州大学学报(医学版),2010,(03):526.
[3]张祥,阚全程#,余祖江,等.PreSTat真核表达载体的构建及表达*[J].郑州大学学报(医学版),2011,(05):706.
 ZHANG Xiang,KAN Quancheng,YU Zujiang,et al.Construction and expression of eukaryotic vector encoding PreSTat[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(04):706.
[4]张艳敏,杜晓峰,张丽梅,等.实时定量PCR和ELISA法快速检测角膜组织HBV和HCV的效果[J].郑州大学学报(医学版),2012,(03):413.
[5]赵志鸿)△,王丽阳),郑立运),等.艾叶挥发油对HBV的抑制作用*[J].郑州大学学报(医学版),2015,(02):301.

备注/Memo

备注/Memo:
【基金项目】国家自然科学基金项目(81570203)
【作者简介】张明智,通信作者,男,1962年10月生,博士,主任医师,研究方向:淋巴瘤,E-mail:mingzhi_zhang1@126.com
更新日期/Last Update: 2019-07-20